Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities episode artwork

EPISODE · Feb 21, 2025 · 8 MIN

Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities

from Medical News Podcast · host PeerDirect Publishing

Drs. Traina and Isaacs share how they determine which patients are appropriate for neoadjuvant therapies and how to address residual disease, as well as potential treatment toxicities.

Episode metadata supplied by the publisher feed · Published Feb 21, 2025

Embed this episode

NOW PLAYING

Navigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities

0:00 8:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 8 minutes long.

When was this Medical News Podcast episode published?

This episode was published on February 21, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!